eFFECTOR Therapeutics Inc. (NASDAQ: EFTR) stock fell -23.83% on Thursday to $0.53 against a previous-day closing price of $0.69. With 3.92 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.27 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $0.7099 whereas the lowest price it dropped to was $0.4680. The 52-week range on EFTR shows that it touched its highest point at $2.97 and its lowest point at $0.34 during that stretch. It currently has a 1-year price target of $5.95.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of EFTR was down-trending over the past week, with a drop of -18.65%, but this was up by 53.29% over a month. Three-month performance surged to 9.57% while six-month performance rose 6.87%. The stock lost -71.25% in the past year, while it has gained 23.71% so far this year. A look at the trailing 12-month EPS for EFTR yields -0.86 with Next year EPS estimates of -0.93. For the next quarter, that number is -0.20. This implies an EPS growth rate of -241.70% for this year and -17.70% for next year.
Float and Shares Shorts:
At present, 42.00 million EFTR shares are outstanding with a float of 38.54 million shares on hand for trading. On May 14, 2023, short shares totaled 77180.0, which was 0.18% higher than short shares on Apr 13, 2023. In addition to Dr. Stephen T. Worland Ph.D. as the firm’s CEO, Pres & Director, Mr. Michael Byrnes M.B.A. serves as its Chief Financial Officer.
Through their ownership of 64.03% of EFTR’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 57.70% of EFTR, in contrast to 15.58% held by mutual funds. Shares owned by individuals account for 1.32%. As the largest shareholder in EFTR with 5.62% of the stake, Sectoral Asset Management, Inc. holds 2,382,644 shares worth 2,382,644. A second-largest stockholder of EFTR, Parallel Advisors LLC, holds 1,693,559 shares, controlling over 3.99% of the firm’s shares. Blackstone Alternative Investment is the third largest shareholder in EFTR, holding 1,308,587 shares or 3.09% stake. With a 0.71% stake in EFTR, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 300,033 shares are owned by the mutual fund manager. The Vanguard Extended Market Index Fu, which owns about 0.22% of EFTR stock, is the second-largest Mutual Fund holder. It holds 94,449 shares valued at 44391.0. Fidelity Extended Market Index Fu holds 0.13% of the stake in EFTR, owning 56,361 shares worth 26490.0.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Mar 30, 2023, EFTR reported revenue of $0.00 and operating income of -$7.88M. The EBITDA in the recently reported quarter was -$7.69M and diluted EPS was -$0.17.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for EFTR since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With EFTR analysts setting a high price target of $10.00 and a low target of $5.50, the average target price over the next 12 months is $7.38. Based on these targets, EFTR could surge 1786.79% to reach the target high and rise by 937.74% to reach the target low. Reaching the average price target will result in a growth of 1292.45% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded EFTR stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 5 while that of sell transactions has risen to 26 over the past year. The total number of shares bought during that period was 85,698 while 285,466 shares were sold.